Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Net Income Growth
104.86%
Quarterly · Period ending:
LCTX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported104.86%period ending
Latest reported104.86%period ending
LCTX Quarterly Net Income YoY % (0.00% → 104.86%)
Year-over-year change
High-resolution chart · PNG
LCTX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 104.8648% | |
| -16.26% | |
| 126.0006% | |
| -881.5755% | |
| -428.8889% | |
| 36.7319% | |
| 31.4555% | |
| 57.3277% | |
| -10.1549% | |
| -49.634% | |
| 24.8505% | |
| -17.1527% | |
| 22.6822% | |
| 38.3096% | |
| 78.0821% | |
| 22.4211% | |
| -41.249% | |
| -400.4944% | |
| -1,526.6732% | |
| -0.8119% | |
| 26.5869% | |
| 83.1409% | |
| 145.3369% | |
| 52.9839% | |
| 78.2832% | |
| -121.3661% | |
| 90.0294% | |
| -124.7359% | |
| -612.503% | |
| 161.8588% | |
| 37.5094% | |
| 365.9242% | |
| 63.8228% | |
| -228.932% | |
| -1,317.1395% | |
| -54.0979% | |
| -147.4602% | |
| 388.0318% | |
| 62.1871% | |
| 328.9667% | |
| 353.3175% | |
| -68.3031% | |
| -27.0305% | |
| -64.8056% | |
| -1.7942% | |
| -25.5383% | |
| 46.1178% | |
| 8.1665% | |
| -26.0992% | |
| -4.9195% | |
| -224.9787% | |
| -81.5882% | |
| -38.3445% | |
| -55.2128% | |
| -12.5788% | |
| -32.6514% | |
| -27.5669% | |
| -47.9223% | |
| -80.5224% | |
| 19.9851% | |
| -89.3077% | |
| -156.2552% | |
| -309.058% | |
| -30.6708% | |
| -53.5831% | |
| 13.581% | |
| 190.7646% | |
| -231.858% | |
| -121.9998% | |
| -218.9204% | |
| -378.8798% | |
| -404.5618% | |
| -92.6255% | |
| 14.0493% | |
| 13.6728% | |
| 37.215% | |
| 48.4794% | |
| -15.8254% | |
| 22.7234% | |
| 18.0753% | |
| -50.8454% | |
| 34.1875% | |
| 10.6165% | |
| 8.1852% | |
| -0.1054% | |
| 55.7751% | |
| 8.3664% | |
| -224.8716% | |
| 41.4115% | |
| -118.7297% | |
| 22.9737% | |
| 162.5397% | |
| 3.6146% | |
| -6.3308% | |
| -24.8312% | |
| 35.9215% | |
| 30.0746% | |
| 25.7771% | |
| 40.7801% | |
| 26.253% |